skipping a week of semaglutide Missing Semaglutide: What Your Body Does taking glp 1 every other

Lack of Standardized Testing: Unlike FDA-approved drugs, compounded medications do not undergo rigorous clinical trials to establish their safety and efficacy, which may pose unknown health risks to patients

with documented symptomatic hypoglycemia occurred in 17.3% and 24.4% of patients when semaglutide 0.5 mg and 1 mg, respectively

It has been fully approved by the UK's medicines regulator (the MHRA)

Primary and regulatory sources prioritised were: product information from the U.S

Nie, Y., Zhang, Y., Liu, B

However, this heterogeneity was considered to be of limited clinical relevance due to the plateau of key outcomes around week 52